Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: Reevaluation of 163 cases

Transplantation

Volumn 95, Issue 3, 2013, Pages 479-488

  Tiede, Christina ^a   Maecker Kolhoff, Britta ^a   Klein, Christoph ^b   Kreipe, Hans ^a   Hussein, Kais ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Posttransplantation lymphoproliferative disease; Prognosis; PTLD; Risk factor; T cells; T PTLD

Indexed keywords

AZATHIOPRINE; STEROID;

ARTICLE; BONE MARROW DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMORADIOTHERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; EPSTEIN BARR VIRUS INFECTION; FOLLOW UP; GRAFT DYSFUNCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOSPLENIC T CELL LYMPHOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; ONSET AGE; ORGAN TRANSPLANTATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; T CELL LYMPHOMA; T CELL POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; VIRUS LOAD;

ADULT; CELL PROLIFERATION; COMORBIDITY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; T-LYMPHOCYTES;

EID: 84873411053     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182762e07     Document Type: Article

References (122)

1. Heuer M, Frühauf NR, Treckmann J, et al. Kidney procurement and transplantation from a surgical perspective. Dtsch Med Wochenschr 2009; 134: 412.
2. Schrem H, Till N, Becker T, et al. Long-term results after liver transplantation. Chirurg 2008; 79: 121.
3. Shroff R, Rees L. The post-transplant lymphoproliferative disorderVa literature review. Pediatr Nephrol 2004; 19: 369.
4. Hussein K, Maecker-Kolhoff B, Klein C, et al. Transplant-associated lymphoproliferation. Pathologe 2011; 32: 152.
5. Swerdlow SH, Webber SA, Chadburn A, et al. Post-transplant lymphoproliferative disorder. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Geneva: WHO Press; 2008: 343Y351.
6. Albalate M, Octavio JG, Echezarreta G, et al. Diffuse T-cell lymphoma in a kidney graft recipient 17 years after transplantation. Nephrol Dial Transplant 1998; 13: 3242.
7. Audouin J, Le Tourneau A, Diebold J, et al. Primary intestinal lymphoma of Ki-1 large cell anaplastic type with mesenteric lymph node and spleen involvement in a renal transplant recipient. Hematol Oncol 1989; 7: 441.
8. Azhir A, Reisi N, Taheri D, et al. Post transplant anaplastic large T-cell lymphoma. Saudi J Kidney Dis Transpl 2009; 20: 646.
9. Beeaff D, Zugerman C, Roenigk HH Jr, et al. Lymphomatoid papulosis occurring in a renal transplant patient. Arch Dermatol 1979; 115: 498.
10. Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003; 102: 4261.
11. Borisch B, Hennig I, Horber F, et al. Enteropathy-associated T-cell lymphoma in a renal transplant patient with evidence of Epstein-Barr virus involvement. Virchows Arch A Pathol Anat Histopathol 1992; 421: 443.
12. Bustillo M, Perez Melon C, Otero Glz A, et al. High grade lymphoma in a post-renal transplant patient. Description of a case and literature review. Nephron 2000; 84: 189.
13. Canöz O, Soyuer I, Taskapan H, et al. T cell extranodal lymphoma case involving pleura and pericardium in a renal transplant patient. Clin Nephrol 2001; 55: 416.
14. Cooper SM, Turner GDH, Hollowood K, et al. Primary cutaneous large cell CD30+ lymphoma in a renal transplant recipient. Br J Dermatol 2003; 149: 426.
15. Coyne JD, Banerjee SS, Bromley M, et al. Post-transplant T-cell lymphoproliferative disorder/T-cell lymphoma: a report of three cases of T-anaplastic large-cell lymphoma with cutaneous presentation and a review of the literature. Histopathology 2004; 44: 387.
16. Defossez-Tribout C, Carmi E, Lok C, et al. Lymphome T cutané après transplantation rénale. Ann Dermatol Venereol 2003; 130: 47.
17. Euvrard S, Noble CP, Kanitakis J, et al. Brief report: successive occurrence of T-cell and B-cell lymphomas after renal transplantation in a patient with multiple cutaneous squamous-cell carcinomas. N Engl J Med 1992; 327: 1924.
18. François A, Lesesve JF, Stamatoullas A, et al. Hepatosplenic gamma/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q. Am J Surg Pathol 1997; 21: 781.
19. Frias C, Lauzurica R, Vaquero M, et al. Detection of Epstein-Barr virus in posttransplantation T cell lymphoma in a kidney transplant recipient: case report and review. Clin Infect Dis 2000; 30: 576.
20. Garvin AJ, Self S, Sahovic EA, et al. The occurrence of a peripheral T cell lymphoma in a chronically immunosuppressed renal transplant recipient. Am J Surg Pathol 1988; 12: 64.
21. Gentile TC, Hadlock KG, Uner AH, et al. Large granular lymphocyte leukaemia occurring after renal transplantation. Br J Haematol 1998; 101: 507.
22. Ghorbani RP, Shokouh-Amiri H, Gaber LW. Intragraft angiotropic large-cell lymphoma of T cell-type in a long-term renal allograft recipient. Mod Pathol 1996; 9: 671.
23. Gill RM, Ferrell LD. Vanishing bile duct syndrome associated with peripheral T cell lymphoma, not otherwise specified, arising in a posttransplant setting. Hepatology 2010; 51: 1856.
24. Griffith RC, Saha BK, Janney CM. Immunoblastic lymphoma of T-cell type in a chronically immunosuppressed renal transplant recipient. Am J Clin Pathol 1990; 93: 280.
25. Güz G, Arican A, Karakayali H, et al. Two renal transplants from one cadaveric donor: one recipient with simultaneous B cell lymphoma and Kaposi's sarcoma, and the other with T cell lymphoma. Nephrol Dial Transplant 2000; 15: 1242.
26. Hacker SM, Knight BP, Lunde NM, et al. A primary central nervous system T cell lymphoma in a renal transplant patient. Transplantation 1992; 53: 691.
27. Hanson MN, Morrison VA, Peterson BA, et al. Posttransplant lymphoproliferative disordersVan aggressive, late complication of solid-organ transplantation. Blood 1996; 88: 3626.
28. Hoshida Y, Li T, Dong Z, et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer 2001; 91: 869.
29. Ichikawa Y, Iida M, Ebisui C, et al. A case study of adult T-cell lymphoma in a kidney transplant patient. Transplant Proc 2000; 32: 1982.
30. Jamali FR, Otrock ZK, Soweid AM, et al. An overview of the pathogenesis and natural history of post-transplant T-cell lymphoma [corrected and republished article originally printed in Leuk Lymphoma 2007;48:1237]. Leuk Lymphoma 2007; 48: 1780.
31. Jenks PJ, Barrett WY, Raftery MJ, et al. Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation. Clin Infect Dis 1995; 21: 992.
32. Jiménez-Heffernan JA, Viguer JM, Vicandi B, et al. Posttransplant CD30 (Ki-1)-positive anaplastic large cell lymphoma. Report of a case with presentation as a pleural effusion. Acta Cytol 1997; 41: 1519.
33. Jonveaux P, Daniel MT, Martel V, et al. Isochromosome 7q and trisomy 8 are consistent primary, nonrandom chromosomal abnormalities associated with hepatosplenic T F/C lymphoma. Leukemia 1996; 10: 1453.
34. Kaplan MA, Jacobson JO, Ferry JA, et al. T-cell lymphoma of the vulva in a renal allograft recipient with associated hemophagocytosis. Am J Surg Pathol 1993; 17: 842.
35. Khan WA, Yu L, Eisenbrey AB, et al. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature. Am J Clin Pathol 2001; 116: 41.
36. Kim HK, Jin SY, Lee NS, et al. Posttransplant primary cutaneous Ki-1 (CD30)+/CD56+ anaplastic large cell lymphoma. Arch Pathol Lab Med 2004; 128: e96.
37. Kim JY, Kim CW, Ahn C, et al. Rapidly developing T-cell posttransplantation lymphoproliferative disorder. Am J Kidney Dis 1999; 34: e3.
38. Kumar S, Kumar D, Kingma DW, et al. Epstein-Barr virus-associated T-cell lymphoma in a renal transplant patient. Am J Surg Pathol 1993; 17: 1046.
39. Kwong YL, Lam CC, Chan TM. Post-transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis. Br J Haematol 2000; 110: 197.
40. Labouyrie E, Morel D, Boiron JM, et al. Peripheral T-cell lymphoma in a chronically immunosuppressed renal transplant patient. Mod Pathol 1995; 8: 355.
41. Lee HK, Kim HJ, Lee EH, et al. Epstein-Barr virus-associated peripheral T-cell lymphoma involving spleen in a renal transplant patient. J Kor Med Sci 2003; 18: 272.
42. Lin WC, Moore JO, Mann KP, et al. Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection. Leuk Lymphoma 1999; 33: 377.
43. Lippman SM, Grogan TM, Carry P, et al. Post-transplantation T cell lymphoblastic lymphoma. Am J Med 1987; 82: 814.
44. Lye WC. Successful treatment of Epstein-Barr virus-associated T-cell cutaneous lymphoma in a renal allograft recipient: case report and review of the literature. Transplant Proc 2000; 32: 1988.
45. Masuda M, Arai Y, Nishina H, et al. Large granular lymphocyte leukemia with pure red cell aplasia in a renal transplant recipient. Am J Hematol 1998; 57: 72.
46. McGregor JM, Yu CCW, Lu QL, et al. Posttransplant cutaneous lymphoma. J Am Acad Dermatol 1993; 29: 549.
47. Michael J, Greenstein S, Schechner R, et al. Primary intestinal posttransplant T-cell lymphoma. Transplantation 2003; 75: 2131.
48. Mukai HY, Kojima H, Suzukawa K, et al. Nasal natural killer cell lymphoma in a post-renal transplant patient. Transplantation 2000; 69: 1501.
49. Ng K, Trotter J, Metcalf C, et al. Extranodal Ki-1 lymphoma in a renal transplant patient. Aust N Z J Med 1992; 22: 51.
50. Olesen LL, Mølby L. Malignant T-cell neoplasia during treatment with azathioprine and prednisone after kidney transplantation. Ugeskr Laeger 1991; 153: 3410.
51. Pascual J, Torrelo A, Teruel JL, et al. Cutaneuos T cell lymphomas after renal transplantation. Transplantation 1992; 53: 1143.
52. Peeters P, Sennesael J, De Raeve H, et al. Hemophagocytic syndrome and T-cell lymphoma after kidney transplantation: a case report. Transpl Int 1997; 10: 471.
53. Pomerantz RG, Campbell LS, Jukic DM, et al. Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk. Arch Dermatol 2010; 146: 513.
54. Raftery MJ, Tidman MJ, Koffman G, et al. Posttransplantation T cell lymphoma of the skin. Transplantation 1988; 46: 475.
55. Rajakariar R, Bhattacharyya M, Norton A, et al. Post transplant T-cell lymphoma: a case series of four patients from a single unit and review of the literature. Am J Transplant 2004; 4: 1534.
56. Ravat FE, Spittle MF, Russell-Jones R. Primary cutaneous T-cell lymphoma occurring after organ transplantation. J Am Acad Dermatol 2006; 54: 668.
57. Rodŕguez-Gil Y, Palencia SI, Ló pez-R?́os F, et al. Mycosis fungoides after solid-organ transplantation: report of 2 new cases. Am J Dermatopathol 2008; 30: 150.
58. Roncella S, Cutrona G, Truini M, et al. Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient. Haematologica 2000; 85: 256.
59. Ross CW, Schnitzer B, Sheldon S, et al. F/C T-cell post-transplantation lymphoproliferative disorder primarily in the spleen. Am J Clin Pathol 1994; 102: 310.
60. Salama S. Primary 'cutaneous' T-cell anaplastic large cell lymphoma, CD30+, neutrophil-rich variant with subcutaneous panniculitic lesions, in a post-renal transplant patient. Am J Dermatopathol 2005; 27: 217.
61. Seckin D, Demirhan B, Oguz Gülec T, et al. Posttransplantation primary cutaneous CD30 (Ki-1)-positive large cell lymphoma. J Am Acad Dermatol 2001; 45: S179.
62. Shiong YS, Lian JD, Lin CY, et al. Epstein-Barr virus-associated T-cell lymphoma of the maxillary sinus in a renal transplant recipient. Transplant Proc 1992; 24: 1929.
63. Stadlmann S, Fend F, Moser P, et al. Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of literature. Hum Pathol 2001; 32: 1264.
64. Steurer M, Stauder R, Grünewald K, et al. Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation. Hum Pathol 2002; 33: 253.
65. Su IC, Lien HC, Chen CM. Primary brain T-cell lymphoma after kidney transplantation: a case report. Surg Neurol 2006; 66: S60.
66. Treaba D, Assad L, Goldberg C, et al. Anaplastic T large cell lymphoma diagnosed by exfoliative cytology in a post renal transplant patient. Diagn Cytopathol 2002; 27: 35.
67. Tsai DE, Aqui NA, Vogl DT, et al. Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene. Am J Transplant 2005; 5: 2070.
68. Tsurumi H, Tani K, Tsuruta T, et al. Adult T-cell leukemia developing during immunosuppressive treatment in a renal transplant recipient [abstract]. Am J Hematol 1992; 41: 292.
69. Ulrich W, Chott A, Watschinger B, et al. Primary peripheral T cell lymphoma in a kidney transplant under immunosuppression with cyclosporine A. Hum Pathol 1989; 20: 1027.
70. Urasaki E, Yamada H, Tokimura T, et al. T-cell type primary spinal intramedullary lymphoma associated with human T-cell lymphotropic virus type I after a renal transplant: case report. Neurosurgery 1996; 38: 1036.
71. van Gorp J, Doornewaard H, Verdonck LF, et al. Posttransplant Tcell lymphoma. Report of three cases and a review of the literature. Cancer 1994; 73: 3064.
72. Venizelos I, Tamiolakis D, Lambropoulou M, et al. An unusual case of posttransplant peritoneal primary effusion lymphoma with T-cell phenotype in a HIV-negative female, not associated with HHV-8. Pathol Oncol Res 2005; 11: 178.
73. Waller EK, Ziemianska M, Bangs CD, et al. Characterization of posttransplant lymphomas that express T-cell-associated markers: immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice. Blood 1993; 82: 247.
74. Ward HA, Russo GG, McBurney E, et al. Posttransplant primary cutaneous T-cell lymphoma. J Am Acad Dermatol 2001; 44: 675.
75. Williams NP, Buchner LM, Shah DJ, et al. Adult T-cell leukemia/lymphoma in a renal transplant recipient: an opportunistic occurrence. Am J Nephrol 1994; 14: 226.
76. Wu H,Wasik M, Przybylski G, et al.Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients. Am J Clin Pathol 2000; 113: 487.
77. Yasunaga C, Kasai T, Nishihara G. Early development of Epstein-Barr virus-associated T-cell lymphoma after a living-related renal transplantation. Transplantation 1998; 65: 1642.
78. Yurtsever H, Kempf W, Laeng RH. Posttransplant CD30+ anaplastic large cell lymphoma with skin and lymph node involvement. Dermatology 2003; 207: e107.
79. Bartakke S, Abla O, Weitzman S. Successful use of alemtuzumab in a child with refractory peripheral T-cell posttransplant lymphoproliferative disorder. J Pediatr Hematol Oncol 2008; 30: 787.
80. Bregman SG, Yeaney GA, Greig BW, et al. Subcutaneous panniculitic T-cell lymphoma in a cardiac allograft recipient. J Cutan Pathol 2005; 32: 366.
81. Chen W, Huang Q, Zuppan CW, et al. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases. Am J Clin Pathol 2009; 131: 632.
82. De Nisi MC, D'Amuri A, Lalinga AV, et al. Posttransplant primary cutaneous CD30 (Ki-1)-positive anaplastic large T-cell lymphoma. A case report. Br J Dermatol 2005; 152: 1068.
83. Draoua HY, Tsao L, Mancini DM, et al. T-cell post-transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience. Br J Haematol 2004; 127: 429.
84. Haldas J, Wang W, Lazarchick J. Post-transplant lymphoproliferative disorders: T-cell lymphoma following cardiac transplant. Leuk Lymphoma 2002; 43: 447.
85. Katugampola RP, Finlay AY, Harper JI, et al. Primary cutaneous CD30+ T-cell lymphoproliferative disorder following cardiac transplantation in a 15-year-old boy with Netherton's syndrome [abstract]. Br J Dermatol 2005; 153: 1041.
86. Kemnitz J, Cremer J, Gebel M, et al. T-cell lymphoma after heart transplantation. Am J Clin Pathol 1990; 94: 95.
87. Lee LY, Harpaz N, Strauchen JA. Posttransplant CD30+ (Ki-1) anaplastic large cell lymphoma: a case report and review of the literature. Arch Pathol Lab Med 2003; 127: 349.
88. Lucioni M, Ippoliti G, Campana C, et al. EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient: case report. Am J Transplant 2004; 4: 1915.
89. Mandel L, Surattanont F, Dourmas M. T-cell lymphoma in the parotid region after cardiac transplant: case report. J Oral Maxillofac Surg 2001; 59: 673.
90. McMullan DM, Radovancevic B, Jackow CM, et al. Cutaneous T-cell lymphoma in a cardiac transplant recipient. Tex Heart Inst J 2001; 28: 203.
91. Pitman SD, Rowsell EH, Cao JD, et al. Anaplastic large cell lymphoma associated with Epstein-Barr virus following cardiac transplant. Am J Surg Pathol 2004; 28: 410.
92. Rolland SL, Seymour RA, Wilkins BS, et al. Post-transplant lymphoproliferative disorders presenting as gingival overgrowth in patients immunosuppressed with ciclosporin. A report of two cases. J Clin Periodontol 2004; 31: 581.
93. Sebire NJ, Malone M, Ramsay AD. Posttransplant lymphoproliferative disorder presenting as CD30+, ALK+, anaplastic large cell lymphoma in a child. Pediatr Dev Pathol 2004; 7: 290.
94. Tsao L, Draoua HY, Mansukhani M, et al. EBV-associated, extranodal NK-cell lymphoma, nasal type of the breast, after heart transplantation. Mod Pathol 2004; 17: 125.
95. Amin A, Burkhart C, Groben P, et al. Primary cutaneous T-cell lymphoma following organ transplantation in a 16-year-old boy. Pediatr Dermatol 2009; 26: 112.
96. Costes-Martineau V, Delfour C, Obled S, et al. Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: a case report and literature review. J Clin Pathol 2002; 55: 868.
97. Dockrell DH, Strickler JG, Paya CV. Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients. Clin Infect Dis 1998; 26: 180.
98. Feher O, Barilla D, Locker J, et al. T-cell large granular lymphocytic leukemia following orthotopic liver transplantation. Am J Hematol 1995; 49: 216.
99. George TI, Jeng M, Berquist W, et al. Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature. Pediatr Blood Cancer 2005; 44: 270.
100. Lundell R, Elenitoba-Johnson KS, Lim MS. T-cell posttransplant lymphoproliferative disorder occurring in a pediatric solid-organ transplant recipient. Am J Surg Pathol 2004; 28: 967.
101. Magro CM, Weinerman DJ, Porcu PL, et al. Post-transplant EBVnegative anaplastic large-cell lymphoma with dual rearrangement: a propos of two cases and review of the literature. J Cutan Pathol 2007; 34: 1.
102. Roelandt PR, Maertens J, Vandenberghe P, et al. Hepatosplenic gammadelta T-cell lymphoma after liver transplantation: report of the first 2 cases and review of the literature. Liver Transpl 2009; 15: 686.
103. Sevmis S, Pehlivan S, Shabazov R, et al. Posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Transplant Proc 2009; 41: 2881.
104. Williams KM, Higman MA, Chen AR, et al. Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma. Pediatr Blood Cancer 2008; 50: 667.
105. Yang F, Li Y, Braylan R, et al. Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation. Pediatr Blood Cancer 2008; 50: 415.
106. Laffitte E, Venetz JP, Aubert JD, et al. Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation. Dermatology 2008; 217: 87.
107. Thein M, Ravat F, Orchard G, et al. Syringotropic cutaneous T-cell lymphoma: an immunophenotypic and genotypic study of five cases. Br J Dermatol 2004; 151: 216.
108. Berho M, Viciana A, Weppler D, et al. T cell lymphoma involving the graft of a multivisceral organ recipient. Transplantation 1999; 68: 1135.
109. Au WY, Lie AK, Lee CK, et al. Late onset post-transplantation lymphoproliferative disease of recipient origin following cytogenetic relapse and occult autologous haematopoietic regeneration after allogeneic bone marrow transplantation for acute myeloid leukaemia. Bone Marrow Transplant 2001; 28: 417.
110. Chang H, Kamel-Reid S, Hussain N, et al. T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders. Am J Clin Pathol 2005; 123: 196.
111. Zutter MM, Durnam DM, Thomas ED, et al. Secondary T-cell lymphoproliferation after marrow transplantation. Am J Clin Pathol 1990; 94: 714.
112. Awaya N, Adachi A, Mori T, et al. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma. Leuk Res 2006; 30: 1059.
113. Yufu Y, Kimura M, Kawano R, et al. Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease. Bone Marrow Transplant 2000; 26: 1339.
114. Wang LC, Lu MY, Yu J, et al. T cell lymphoproliferative disorder following bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 2000; 26: 89389.
115. Collins MH, Montone KT, Leahey AM, et al. Post-transplant lymphoproliferative disease in children. Pediatr Transplant 2001; 5: 250.
116. Vakiani E, Basso K, Klein U, et al. Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. Hematol Oncol 2008; 26: 199.
117. Khedmat H, Taheri S. Early onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Ann Transplant 2009; 14: 74.
118. Styczynski J, Einsele H, Gil L, et al. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases. Transpl Infect Dis 2009; 11: 383.
119. Capello D, Rasi S, Oreste P, et al. Molecular characterization of posttransplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients. J Pathol 2009; 218: 478.
120. Maecker B, Jack T, Zimmermann M, et al. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation. J Clin Oncol 2007; 25: 4902.
121. Meehan SM, Domer P, Josephson M, et al. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol 2001; 32: 205.
122. Leblond V, Sutton L, Dorent R, et al. Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center. J Clin Oncol 1995; 13: 961.